Novo Integrated Sciences Inc (NVOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 03-2017 | 02-2017 | 12-2016 | 11-2016 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -37 | -100 | N/A | -43 | -122 |
| Depreciation Amortization | N/A | 31 | N/A | 16 | N/A |
| Accounts receivable | N/A | -318 | N/A | -48 | N/A |
| Accounts payable and accrued liabilities | -14 | 90 | N/A | -20 | -10 |
| Other Working Capital | -21 | -37 | N/A | 62 | -10 |
| Other Operating Activity | 18 | 228 | 0 | 67 | 56 |
| Operating Cash Flow | $-54 | $-106 | $N/A | $35 | $-86 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -17 | N/A | -14 | N/A |
| Other Investing Activity | 0 | 378 | 0 | 377 | 0 |
| Investing Cash Flow | $0 | $360 | $N/A | $363 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 15 | N/A | N/A | N/A | 85 |
| Other Financing Activity | 0 | -260 | 0 | -203 | 0 |
| Financing Cash Flow | $15 | $-260 | $N/A | $-203 | $85 |
| Exchange Rate Effect | N/A | -1 | N/A | -5 | N/A |
| Beginning Cash Position | 54 | 110 | N/A | 110 | 14 |
| End Cash Position | 15 | 103 | N/A | 300 | 13 |
| Net Cash Flow | $-39 | $-7 | $N/A | $190 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54 | -106 | N/A | 35 | -86 |
| Capital Expenditure | N/A | -17 | N/A | -14 | N/A |
| Free Cash Flow | -54 | -123 | 0 | 20 | -86 |